Epoch Investment Partners Inc. Sells 17,134 Shares of Agilent Technologies, Inc. $A

Epoch Investment Partners Inc. lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 8.1% in the first quarter, Holdings Channel.com reports. The firm owned 194,113 shares of the medical research company’s stock after selling 17,134 shares during the period. Epoch Investment Partners Inc.’s holdings in Agilent Technologies were worth $22,125,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. State Street Corp boosted its position in shares of Agilent Technologies by 1.9% during the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after buying an additional 241,029 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after buying an additional 25,139 shares during the last quarter. Morgan Stanley grew its holdings in Agilent Technologies by 15.9% during the fourth quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after buying an additional 692,202 shares in the last quarter. Finally, Norges Bank purchased a new stake in Agilent Technologies in the 4th quarter valued at $549,158,000.

Agilent Technologies Stock Down 0.8%

Shares of NYSE:A opened at $138.65 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a market capitalization of $39.16 billion, a PE ratio of 27.84, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The business has a fifty day moving average price of $129.75 and a two-hundred day moving average price of $125.55. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts forecast that Agilent Technologies, Inc. will post 6.01 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on A. Jefferies Financial Group began coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price for the company. Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. Finally, HSBC cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.